As of December 2024, Kolon TissueGene has a market cap of $1.06B. This makes Kolon TissueGene the world's 7697th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $481.33M | 16.30% |
2023 | $413.88M | 1.35% |
2022 | $408.37M | - |